Get started
Author

G. Quack

Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist—a review of preclinical data
1999 · C.G. Parsons, W. Danysz, et al. · Neuropharmacology · 893
Glutamate in CNS disorders as a target for drug development: an update
1998 · C.G. Parsons, W. Danysz, et al. · Drug News & Perspectives · 437
Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents — preclinical studies
1997 · W. Danysz, C.G. Parsons, et al. · Neuroscience & Biobehavioral Reviews · 325
Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo
1995 · C.G. Parsons, G. Quack, et al. · Neuropharmacology · 314
Neuroprotection by memantine against neurodegeneration induced by β-amyloid(1–40)
2002 · J.J Miguel-Hidalgo, X.A Alvarez, et al. · Brain Research · 271
Neuroprotective and symptomatological action of memantine relevant for alzheimer’s disease — a unified glutamatergic hypothesis on the mechanism of action
2000 · Wojciech Danysz, Chris G. Parsons, et al. · Neurotoxicity Research · 266
Novel Systemically Active Antagonists of the Glycine Site of the N-Methyl-d-aspartate Receptor: Electrophysiological, Biochemical and Behavioral Characterization
1997 · Chris G. Parsons, Wojciech Danysz, et al. · Journal of Pharmacology and Experimental Therapeutics · 195
L -Ornithine- L -aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure
1999 · Christopher Rose, Adrianna Michalak, et al. · Hepatology · 158
Potential Antidepressive Properties of Amantadine, Memantine and Bifemelane
1993 · Elzbieta Moryl, Wojciech Danysz, et al. · Pharmacology & Toxicology · 156
Cerebrospinal fluid and serum concentrations of the N-methyl-d-aspartate (NMDA) receptor antagonist memantine in man
1995 · J. Kornhuber, G. Quack · Neuroscience Letters · 155
Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats
1997 · B A Vogels, M A Maas, et al. · Hepatology · 144
PDF
Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization
1999 · Chris G Parsons, Wojciech Danysz, et al. · Neuropharmacology · 133
How to overcome resistance of influenza A viruses against adamantane derivatives
1998 · C Scholtissek, G Quack, et al. · Antiviral Research · 125
Therapeutic brain concentration of the NMDA receptor antagonist amantadine
1995 · J. Kornhuber, G. Quack, et al. · Neuropharmacology · 114
Infusion of (+)-MK-801 and memantine — contrasting effects on radial maze learning in rats with entorhinal cortex lesion
1996 · Wojciech Zajaczkowski, Günter Quack, et al. · European Journal of Pharmacology · 110
L-Ornithine-L-Aspartate in Experimental Portal-Systemic Encephalopathy: Therapeutic Efficacy and Mechanism of Action
1998 · C. Rose, A. Michalak, et al. · Metabolic Brain Disease · 93
Are NMDA antagonistic properties relevant for antiparkinsonianlike activity in rats?—Case of amantadine and memantine
1994 · W. Danysz, M. Gossel, et al. · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · 73
Modulation of NMDA receptors by glycine ? introduction to some basic aspects and recent developments
1998 · C. G. Parsons, W. Danysz, et al. · Amino Acids · 62
PET studies of 18 F-memantine in healthy volunteers
2002 · S.M. Ametamey, M. Bruehlmeier, et al. · Nuclear Medicine and Biology · 48
GlycineB antagonists as potential therapeutic agents
1998 · W. Danysz, C. G. Parsons, et al. · Amino Acids · 44
Memantine, amantadine, and L-deprenyl potentiate the action of L-DOPA in monoamine-depleted rats
1994 · G. Skuza, Z. Rogoz, et al. · Journal of Neural Transmission · 43
Evidence for Lysosomotropism of Memantine in Cultured Human Cells: Cellular Kinetics and Effects of Memantine on Phospholipid Content and Composition, Membrane Fluidity and β‐Adrenergic Transmission
1993 · U. E. Honegger, G. Quack, et al. · Pharmacology & Toxicology · 42
NMDA channel blockers: memantine and amino-aklylcyclohexanes - In vivo characterization
2000 · W. Danysz, C. G. Parsons, et al. · Amino Acids · 41
Microdialysis studies with amantadine and memantine on pharmacokinetics and effects on dopamine turnover.
1995 · G Quack, M Hesselink, et al. · PubMed · 41
Memantine and the amino-alkyl-cyclohexane MRZ 2/579 are moderate affinity uncompetitive NMDA receptor antagonists - in vitro characterisation
2000 · C. G. Parsons, W. Danysz, et al. · Amino Acids · 39
Works count: 57
Citation count: 4,662
H-index: 28
I10-index: 37
Year
Topic
Type